Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pien Tze Huang for hepatic fibrosis in chronic hepatitis B
ChiCTR2000035128Phase 4Not yet recruiting
- Sponsor
- Shuguang Hospital
- Start
- Mar 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Pien Tze Huang in hepatic fibrosis and Chronic Hepatitis B (CHB) (2 arms), sponsored by Shuguang Hospital. Primary endpoints: Routine blood test, Urinalysis and 18 more. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
Pien Tze Huang
03
Conditions
hepatic fibrosisChronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2000035128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035128.